JANET ZANI: Open Payments
NPI 1467460659 · BURLINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,495 in 23 payments from 10 companies in 2025. Trend: 2023 $1,549 · 2024 $2,333 · 2025 $2,495
Travel & lodging: $1,374Food & beverage: $1,121
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 7 | $1,415 |
| Abbott Laboratories | 7 | $747 |
| Otsuka America Pharmaceutical, Inc. | 1 | $112 |
| PFIZER INC. | 2 | $107 |
| Genentech USA, Inc. | 1 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| Neurelis, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
| ABBVIE INC. | 1 | $14 |
Products named: VNS Therapy, INFINITY, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, REXULTI, NURTEC ODT, Ocrevus, KESIMPTA, VALTOCO.
Industry payments across MA — which companies pay providers there.
